Skip to main content

Header Menu

Show — Header Menu Hide — Header Menu
  • International Coalition of Medicines Regulatory Authorities
  • Participating Regulatory Authorities
Home

ICMRA provides a global architecture to support enhanced communication, information sharing, crisis response and address regulatory science issues.

Main navigation

Show — Main navigation Hide — Main navigation
  • COVID-19
  • About Us
  • Meetings
    • 2017 ICMRA Kyoto
    • 2018 ICMRA Basel
    • 2018 ICMRA Summit Washington
    • 2019 ICMRA San Diego
    • 2019 ICMRA Summit Rome
  • Strategic Initiatives
  • Relationships
  • News
  • Links
  • Contact Us

News

  • Statements and Press Releases
    • Antimicrobial Resistance Statement (July 2019)
      Antimicrobial Resistance Statement (French)
      Antimicrobial Resistance Statement (Portuguese)
      Antimicrobial Resistance Statement (Spanish)
    • ICMRA statement about confidence in biosimilar products (for healthcare professionals) (July 2019)
    • ICMRA statement about confidence in biosimilar products (for patients and the public) (July 2019)
    • Election of New Chair and Vice Chairs of ICMRA (July 2019)
    • Zika Virus Disease Press Release (September 2016)
    • Ebola Statement (August 2014)
  • Archives
    • WHO Drug Information Vol. 29, No. 1, 2015

Recent content

  • COVID-19
    3 hours 11 minutes ago
  • ICMRA Statement on Pre-Requisites for Regulatory Flexibility in Pharmaceutical Manufacturing Change Management
    4 hours 50 minutes ago
  • ICMRA workshop on enabling manufacturing capacity in the COVID-19 pandemic
    1 week 3 days ago
  • Innovation
    1 month 3 weeks ago
  • Supply Chain Integrity
    2 months ago

© 2021 ICMRA

Website designed by Swissmedic and maintained by the Pharmaceuticals and Medical Devices Agency

Footer menu

Show — Footer menu Hide — Footer menu
  • Contact
  • Disclaimer
Back to top